Literature DB >> 26520199

[Colonoscopy in the screening, follow-up and treatment of colorectal cancer and precursor lesions].

Maria Pellisé1.   

Abstract

Endoscopic polypectomy reduces the incidence of colorectal cancer and mortality due to this disease. Interval cancer is the marker par excellence of the effectiveness and quality of screening and surveillance programs. Interval cancer is defined as colorectal cancer appearing after a negative screening or surveillance test (whether colonoscopy or another type of test) for colorectal cancer and before the recommended date of the following screening test. It has been estimated that up to 75% of interval colorectal cancers may be due to poor endoscopic technique. Therefore, to reduce mortality from this disease, diagnostic and therapeutic colonoscopy must be carried out with high quality standards. In the latest congress of the American Gastroenterological Association, presentations were given on studies designed to analyse interval cancer and its possible causes, as well as to evaluate endoscopic techniques that could improve detection of polyps or optimize their complete resection. Likewise, strategies have begun to be evaluated that would allow rationalization of efforts and resources to achieve screening of the maximum number of individuals, with high quality standards, but without completely overloading the healthcare system. Finally, the congress also devoted substantial space to presentations on the management of post-polypectomy complications and large polyps.
Copyright © 2015 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Clips; Colonoscopia; Colonoscopy; Colorectal cancer; Complicaciones; Complications; Cribado; Cáncer colorrectal; Cáncer de intervalo; Interval cancer; Narrow band imaging; Polipectomía; Poly; Polypectomy; Pólipo; Screening; Surveillance; Vigilancia

Mesh:

Year:  2015        PMID: 26520199     DOI: 10.1016/S0210-5705(15)30022-4

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  2 in total

1.  The incidence of colorectal cancer in patients with previously removed polyp(s)-a cross-sectional study.

Authors:  Ruud J L F Loffeld; Boris Liberov; Pascale E P Dekkers
Journal:  J Gastrointest Oncol       Date:  2018-08

2.  Ginsenoside Rh1 inhibits colorectal cancer cell migration and invasion in vitro and tumor growth in vivo.

Authors:  Xi Lyu; Xiaodong Xu; Ailin Song; Jinyi Guo; Yawu Zhang; Youcheng Zhang
Journal:  Oncol Lett       Date:  2019-08-14       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.